EDITAS MEDICINE INC reports a Return on Equity (ROE) of -2,471.73%.

What is EDIT's dividend yield?

EDITAS MEDICINE INC offers a dividend yield of 0.00%.

What is EDIT's Deepscope Quality Score?

Deepscope rates EDIT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy EDIT?

Deepscope's AI Timing Score for EDIT is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does EDIT belong to?

EDITAS MEDICINE INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu EDIT (NASDAQ) | EDITAS MEDICINE INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

EDIT

EDITAS MEDICINE INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 2.78

-0.04 (-1.42%) Day Change

Watchlist Portfolio Compare Chart

3.22

D/E

-2,471.7%

ROE

-73.0%

ROA

0.00%

Div Yield

EDITAS MEDICINE INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.78 Price -0.04 (-1.42%) Day Change	NEWS SCORE: 98

EDIT Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.78
PBV / Sector	98.18 / 4.48
Earning Per Share	-0.70

PE / Sector	N/A / 16.68
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	9.53 M
Average 1W Daily Value	11.78 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-281.59 / 450.37
NPM Average (%) / Sector	-528.63 / -1,506.30
NPM Change Average (%) / Sector	29.54 / 4,941.44 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-72.96 / 30.83
ROA Average (%) / Sector	-59.72 / -347.12
ROA Change Average (%) / Sector	28.01 / 5,126.35 GREAT
ROE (%) / Sector	-2,471.73 / -3.04
ROE Average (%) / Sector	-667.08 / 40.76
ROE Change Average (%) / Sector	208.34 / 2,110.63 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Chi tiết đăng ký

Analyze Date	2026-06-04 09:24:23
Symbol	EDIT
Name	EDITAS MEDICINE INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	153.46 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	432.76 / 8,483.11

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 11 Hurley Street, Cambridge, MA, United States, 02141

Phone: 617 401 9000

Website: https://www.editasmedicine.com

Employees: 87

Sector: Healthcare >> Biotechnology

Description: Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.